Drug developed at Duke approved by FDA as only therapy for congenital athymia

Press/Media

Period	12 Oct 2021

Media coverage

Title	Drug developed at Duke approved by FDA as only therapy for congenital athymia
Media name/outlet	News-Medical.Net
Country/Territory	Australia
Date	12/10/21
URL	https://www.news-medical.net/news/20211011/Drug-developed-at-Duke-approved-by-FDA-as-only-therapy-for-congenital-athymia.aspx
Persons	Paul Martin